 | Up a level |
Klement, Rainer J; Abbasi-Senger, N; Adebahr, S; Alheid, H; Allgaeuer, M; Becker, G; Blanck, O; Boda-Heggemann, J; Brunner, T; Duma, M; Eble, M J; Ernst, I; Gerum, S; Habermehl, D; Hass, P; Henkenberens, C; Hildebrandt, G; Imhoff, D; Kahl, H; Klass, Natalie Désirée; ... (2019). The impact of local control on overall survival after stereotactic body radiotherapy for liver and lung metastases from colorectal cancer: a combined analysis of 388 patients with 500 metastases. BMC cancer, 19(1), p. 173. BioMed Central 10.1186/s12885-019-5362-5
Sidler, D; Brockmann, A; Mueller, J; Nachbur, U; Corazza, N; Renzulli, P; Hemphill, A; Brunner, T (2012). Thiazolide-induced apoptosis in colorectal cancer cells is mediated via the Jun kinase-Bim axis and reveals glutathione-S-transferase P1 as Achilles' heel. Oncogene, 31(37), pp. 4095-106. Basingstoke, UK: Nature Publishing Group 10.1038/onc.2011.575
Hostettler, N; Bianchi, P; Gennari-Moser, Carine; Kassahn, D; Schoonjans, K; Corazza, N; Brunner, T (2012). Local glucocorticoid production in the mouse lung is induced by immune cell stimulation. Allergy, 67(2), pp. 227-234. Oxford: Wiley-Blackwell 10.1111/j.1398-9995.2011.02749.x
Sidler, D; Renzulli, P; Schnoz, C; Berger, B; Schneider-Jakob, S; Flück, C; Inderbitzin, D; Corazza, N; Candinas, D; Brunner, T (2011). Colon cancer cells produce immunoregulatory glucocorticoids. Oncogene, 30(21), pp. 2411-9. Basingstoke, UK: Nature Publishing Group 10.1038/onc.2010.629
Schneider-Jakob, S; Corazza, N; Badmann, A; Sidler, D; Stuber-Roos, R; Keogh, A; Frese, S; Tschan, M; Brunner, T (2010). Synergistic induction of cell death in liver tumor cells by TRAIL and chemotherapeutic drugs via the BH3-only proteins Bim and Bid. Cell death & disease, 1(e86), e86. London: Nature Publishing Group 10.1038/cddis.2010.66
Kassahn, D; Nachbur, U; Conus, S; Micheau, O; Schneider, P; Simon, H-U; Brunner, T (2009). Distinct requirements for activation-induced cell surface expression of preformed Fas/CD95 ligand and cytolytic granule markers in T cells. Cell death and differentiation, 16(1), pp. 115-24. Basingstoke: Nature Publishing Group 10.1038/cdd.2008.133
Brumatti, G; Yon, M; Castro, F A; Bueno-da-Silva, A E B; Jacysyn, J F; Brunner, T; Amarante-Mendes, G P (2008). Conversion of CD95 (Fas) Type II into Type I signaling by sub-lethal doses of cycloheximide. Experimental cell research, 314(3), pp. 554-63. San Diego, Calif.: Elsevier 10.1016/j.yexcr.2007.11.003
Kassahn, D; Nachbur, U; Brunner, T (2007). CD95L pro-drug: a novel Swiss Army Knife in cancer therapy? Cell death and differentiation, 14(3), pp. 393-4. Basingstoke: Nature Publishing Group 10.1038/sj.cdd.4402069
